Quanterix Corporation (QTRX) Financial Analysis & Valuation | Quarter Chart
Quanterix Corporation (QTRX)
QTRXPrice: $4.72
Fair Value: 🔒
🔒score
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, ... more
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immu... more
Description
Shares
| Market Cap | $221.56M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Everett V. Cunningham |
| IPO Date | 2017-12-07 | CAGR | 0.31% |
| Employees | 471 | Website | www.quanterix.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.01% | Total Yield | 0.01% |
QTRX chart loading...
Fundamentals
Technicals
| Enterprise Value | $150.50M | P/E Ratio | -1.88 |
| Forward P/E | -1.6 | PEG Ratio | — |
| P/S Ratio | 8508037170.76 | P/B Ratio | 3056849829.56 |
| P/CF Ratio | -30398908349.02 | P/FCF Ratio | -32618810162.31 |
| EPS | $-2.51 | EPS Growth 1Y | 119.81% |
| EPS Growth 3Y | -12.41% | EPS Growth 5Y | 100.9% |
| Revenue Growth 1Y | -2.61% | Gross Margin | 0.56% |
| Operating Margin | -0.72% | Profit Margin | -0.56% |
| ROE | -0.22% | ROA | -0.19% |
| ROCE | -0.27% | Current Ratio | 6.68 |
| Quick Ratio | 6.06 | Cash Ratio | 2.76 |
| Debt/Equity | 0.12 | Interest Coverage | — |
| Altman Z Score | 0.18 | Piotroski Score | 2 |